Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Chronic Obstructive Pulmonary Disease (COPD) Research, and Venous Thromboembolism Diagnosis and Management.
Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment
Lower Airway and Oral Microbiome Dysbiosis in Patients with Long COVID Post-Hospitalisation: A UK Multicentre, Prospective Cohort Study
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
Management of pulmonary hypertension in special conditions
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Cohort Profile: Post-hospitalisation COVID-19 study (PHOSP-COVID)
One year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis
Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19
Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
Physical, cognitive and mental health impacts of COVID-19 following hospitalisation – a multi-centre prospective cohort study
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood
Clinical characteristics with inflammation profiling of Long-COVID and association with one-year recovery following hospitalisation in the UK: a prospective observational study
Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure
Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1)
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome
Bayesian Inference Associates Rare <i>KDR</i> Variants With Specific Phenotypes in Pulmonary Arterial Hypertension